Hydrofarm Holdings Group, Inc. — Q2 2023 Form 10-Q
Reporting period: Three and six months ended June 30, 2023. Financial statements are unaudited. Unless otherwise noted, figures are U.S. dollars in millions.
Business context
Hydrofarm manufactures and distributes equipment and supplies for controlled environment agriculture, primarily in the United States and Canada. Management attributed continued weak results to agricultural oversupply, particularly in the cannabis industry, which has pressured customer demand and sales.
Key financial results
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Net sales | $63.1 | $97.5 | $125.2 | $208.9 |
| Gross profit / margin | $14.5 / 23.0% | $7.3 / 7.5% | $25.9 / 20.6% | $23.9 / 11.5% |
| Operating loss | $(9.0) | $(208.2) | $(22.0) | $(234.6) |
| Net loss | $(12.9) | $(203.3) | $(29.7) | $(226.6) |
| Diluted loss per share | $(0.28) | $(4.53) | $(0.66) | $(5.06) |
| Operating cash flow | Not stated separately | Not stated separately | $1.0 | $7.3 |
- Q2 sales declined 35.3%; first-half sales declined 40.0%. Management attributed the Q2 decrease mainly to a 32.5% drop in volume, alongside lower price/mix and unfavorable foreign exchange. First-half volume fell 38.3%.
- Gross margin improved substantially year over year, but sales contraction continued to weigh on results. Management cited lower inventory provisions, a greater mix of higher-margin proprietary brands, lower freight and labor costs, and improved productivity. These benefits were partly offset by lower sales and restructuring costs.
- SG&A was $23.5 million in Q2, down 9.6%, and $47.9 million in the first half, down 27.7%. First-half comparison benefited from lower amortization and reduced compensation, stock-based compensation, and acquisition and integration costs.
- The much smaller operating and net losses versus 2022 primarily reflect the absence of the prior-year $189.6 million goodwill impairment; 2022 first-half impairments also included a $2.6 million note-receivable charge. These comparisons do not indicate a return to profitability.
Financial position and liquidity
- At June 30, cash and cash equivalents were $26.7 million, current assets $146.0 million, and current liabilities $35.6 million. Working capital was approximately $110.3 million.
- Debt was $118.7 million on the balance sheet, net of unamortized discount and financing costs; the Term Loan principal was $123.1 million. The loan is variable-rate, matures October 2028, and had an effective rate of 11.47% in Q2. Interest expense rose to $3.8 million in Q2 and $7.5 million in the first half, primarily due to higher variable rates.
- The $55 million revolving facility had no borrowings at quarter-end; approximately $34 million was available before the minimum fixed-charge coverage covenant would apply. The company reported compliance with debt covenants. A 100-basis-point rate increase would add an estimated $1.1 million of annual interest expense on variable-rate debt.
- First-half operating cash flow was $1.0 million, versus $7.3 million a year earlier. Investing used $3.3 million, mainly for capital expenditures. Financing provided $7.4 million, primarily from an $8.6 million sale-leaseback, partly offset by scheduled debt repayments.
- Total lease liabilities were $71.4 million, including $61.2 million of operating lease principal and $10.2 million of finance lease principal.
Material changes, outlook and risks
- The restructuring plan narrowed the primary product portfolio by roughly one-third and brands by one-fifth, and included facility consolidation, relocations, and headcount reductions. First-half restructuring charges were $2.2 million; cumulative costs since the plan began in Q4 2022 included $6.8 million of inventory markdowns and $3.1 million primarily for facility relocations and terminations. Remaining restructuring liabilities were $0.5 million.
- Management expected to complete remaining actions in the second half of 2023 and said it may begin a second phase, potentially including U.S. manufacturing consolidations. Additional cash and non-cash charges are possible, and expected savings may not be achieved. No quantitative sales or earnings guidance is provided.
- Management believed operating cash flows, cash on hand, and revolver availability would support operations, debt service, capital expenditures, leases, and working capital for the next 12 months, while cautioning that cash generation and future borrowing availability are not assured.
- The January 2023 Eugene, Oregon property sale-leaseback generated $8.6 million and created a 15-year lease, with annual rent starting at approximately $0.7 million. It is accounted for as a failed sale-leaseback, with the property retained and a corresponding financial liability recognized.
- Key risks include persistent industry oversupply and weak demand, further inventory or asset impairments, restructuring execution and costs, high variable-rate debt expense, access to liquidity and covenant headroom, long-term lease obligations, currency movements, and potential disruptions at financial institutions. Management reported no known legal proceeding expected to have a material adverse effect.
- Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter. The filing also notes non-affiliate market capitalization below $60 million, resulting in non-accelerated filer status for SEC purposes effective December 31, 2023.
Important facts for investors to verify
- Whether sales volumes and customer demand stabilize, particularly in cannabis-related markets, and whether improved gross margins persist as inventory provisions normalize.
- Actual cash generation, borrowing availability under the asset-based revolver, covenant headroom, and the effect of variable rates on debt service.
- Remaining and any second-phase restructuring costs, timing, cash impact, and realized cost savings.
- Leaseback obligations and the use of its proceeds, along with the company’s ability to meet debt, lease, and supplier commitments.
- Whether further inventory valuation adjustments, impairments, or other charges become necessary as market conditions evolve.